Marcelo Langer Wroclawski

Learn More
BACKGROUND Chemotherapy can reduce serum prostate-specific antigen (PSA) levels and relieve pain in some patients with castration-resistant prostate cancer (CRPC). To improve therapeutic efficacy(More)